References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Lenox-Smith et al., 2003",244,venlafaxine: 75-150 mg/day,NA,61.5,28,48,12.3,Wyeth Pharmaceuticals,24,dsm-iv
"Lenox-Smith et al., 2003",244,placebo,NA,56.6,28,46,20.5,Wyeth Pharmaceuticals,24,dsm-iv
